Send to:

Choose Destination
See comment in PubMed Commons below
Future Med Chem. 2012 Dec;4(18):2279-94. doi: 10.4155/fmc.12.178.

Hits, leads and drugs against malaria through diversity-oriented synthesis.

Author information

  • 1Chemical Biology Platform, Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA.


Malaria is a devastating infectious disease and approximately half the world's population is at risk. Since vaccination is not yet available, small-molecule-based medicines are currently the best option for the treatment of patients suffering from malaria and combating the spread of infection. Development of resistance against existing drugs has created a need for new types of small molecules to be screened against Plasmodium falciparum, the etiological agent of malaria. The advent of diversity-oriented synthesis has enabled access to novel chemical structures. Evaluation of diversity-oriented synthesis compounds in phenotypic assays for growth inhibition of P. falciparum has resulted in novel hits, leads and even investigational drugs against malaria.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk